Polar Capital Holdings Plc - Dec 31, 2024 SCHEDULE 13G/A Report for Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share (ELVN)

Filing Manager
Polar Capital Holdings Plc
Reporting Manager
Polar Capital Holdings Plc
Security
Enliven Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
ELVN
Shares outstanding
48.9M shares
Disclosed Ownership
2.39M shares
Ownership
4.89%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 09:17 AM
Date of event
Dec 31, 2024
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Polar Capital Holdings Plc 4.89% 2.39M 2.39M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer
Polar Capital LLP 4.89% 2.39M 2.39M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer
Polar Capital Funds PLC - Biotechnology Fund 4.89% 2.39M 2.39M 0 /s/ Nicholas Farren Nicholas Farren - Chief Operating Officer